BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10754305)

  • 1. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
    Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
    J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig.
    Brady GF; Congdon KL; Clark AG; Sackey FN; Rudolph EH; Radic MZ; Foster MH
    J Immunol; 2004 May; 172(9):5313-21. PubMed ID: 15100270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory.
    Koenig-Marrony S; Soulas P; Julien S; Knapp AM; Garaud JC; Martin T; Pasquali JL
    J Immunol; 2001 Feb; 166(3):1463-70. PubMed ID: 11160185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells.
    Lang J; Arnold B; Hammerling G; Harris AW; Korsmeyer S; Russell D; Strasser A; Nemazee D
    J Exp Med; 1997 Nov; 186(9):1513-22. PubMed ID: 9348309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.
    Corcos D; Grandien A; Vazquez A; Dunda O; Lorès P; Bucchini D
    J Immunol; 2001 Mar; 166(5):3083-9. PubMed ID: 11207259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
    Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
    J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
    Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
    J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T15-idiotype-negative B cells dominate the phosphocholine binding cells in the preimmune repertoire of T15i knockin mice.
    Hu L; Rezanka LJ; Mi QS; Lustig A; Taub DD; Longo DL; Kenny JJ
    J Immunol; 2002 Feb; 168(3):1273-80. PubMed ID: 11801665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice.
    Seo S; Buckler J; Erikson J
    J Immunol; 2001 Mar; 166(6):3710-6. PubMed ID: 11238611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
    Middendorp S; Hendriks RW
    J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncation of the mu heavy chain alters BCR signalling and allows recruitment of CD5+ B cells.
    Zou X; Ayling C; Xian J; Piper TA; Barker PJ; Brüggemann M
    Int Immunol; 2001 Dec; 13(12):1489-99. PubMed ID: 11717190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A VH11V kappa 9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro.
    Chumley MJ; Dal Porto JM; Kawaguchi S; Cambier JC; Nemazee D; Hardy RR
    J Immunol; 2000 May; 164(9):4586-93. PubMed ID: 10779761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive and negative selection of antigen-specific B cells in transgenic mice expressing variant forms of the V(H)1 (T15) heavy chain.
    Kenny JJ; Derby EG; Yoder JA; Hill SA; Fischer RT; Tucker PW; Claflin JL; Longo DL
    Int Immunol; 2000 Jun; 12(6):873-85. PubMed ID: 10837415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
    Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
    J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin.
    Goodyear CS; Narita M; Silverman GJ
    J Immunol; 2004 Mar; 172(5):2870-7. PubMed ID: 14978088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activation.
    Widhopf GF; Brinson DC; Kipps TJ; Tighe H
    J Immunol; 2004 Feb; 172(4):2092-9. PubMed ID: 14764674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of a recombined Ig heavy chain transgene in B-lineage cells of transgenic mice.
    Heinzelmann A; Kumar S; Noggle S; Goedegebuur I; Sauer KM; Rath S; Durdik JM
    J Immunol; 1998 Jul; 161(2):666-73. PubMed ID: 9670941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Types of tolerance seen in autoreactive phosphocholine-specific B cells are dependent on the idiotype of the receptors expressed.
    Mi QS; Kenny JJ
    Cell Mol Immunol; 2013 Jul; 10(4):311-6. PubMed ID: 23624878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.